Decision expected in landmark opioid trial against Johnson & Johnson - CBS News
Decision expected in landmark opioid trial against Johnson & Johnson CBS News
Ruling in Oklahoma case will determine whether Johnson & Johnson and subsidiary Janssen downplayed addiction risks while marketing opioid painkillers.
Comments
Post a Comment